Mergers & Antitrust Law News

Medical Technology Deals a Question of When, Not If, Citi Says

May 8, 2020, 1:18 PM

The pace of mergers and acquisitions has plunged during the pandemic but the return of takeovers for companies in the medical technology sector is a given, according to one Citi analyst.

“As the immediacy of the crises seems to be easing, investor conversations have begun to turn to consolidation,” analyst Joanne Weunsch said.

“M&A is always a matter of when the time is ‘right’ for both parties,” she wrote in a note to clients. Deals are likely to come from “the usual suspects with balance sheet flexibility,” her list of potential buyers includes large devicemakers like Abbott Laboratories, Baxter...

To read the full article log in. To learn more about a subscription click here.